Fig. 2From: Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19Treatment process from the admission to the discharge of the patient. GM gentamicin, AMP ampicillin, CLI clindamycin, LEV levofloxacin, MEM meropenem, COL colistin, TIG tigecyclineBack to article page